Arecor Therapeutics plc (FRA:6UI)

Market Cap	28.73M +73.1%
Revenue (ttm)	1.96M -66.1%
Net Income	761.14K
EPS	0.02
Shares Out	n/a
PE Ratio	37.75
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	24
Open	0.9250
Previous Close	0.9250
Day's Range	0.9250 - 0.9250
52-Week Range	0.4840 - 0.9350
Beta	n/a
RSI	74.86
Earnings Date	Apr 13, 2026

About Arecor Therapeutics

Arecor Therapeutics plc, a clinical stage biotechnology company, develops innovative medicines that address significant unmet patient needs in the United Kingdom. The company through its proprietary reformulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It also offers Ogluo which is used to treat severe hypoglycaemia events in patients with diabetes;...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2007
• Employees: 44
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 6UI

Financial Performance

Financial numbers in GBP